CWMK
JAZZ icon

Caliber Wealth Management (Kansas)’s Jazz Pharmaceuticals JAZZ Stock Holding History

Caliber Wealth Management (Kansas)’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$205K Sell
850
-415
-33% -$90.9K 0.02% 294
2026
Q1 		$239K Sell
1,265
-504
-28% -$88.1K 0.03% 244
2025
Q4 		$301K Sell
1,769
-409
-19% -$62.7K 0.03% 216
2025
Q3 		$287K Sell
2,178
-846
-28% -$101K 0.03% 211
2025
Q2 		$321K Buy
3,024
+745
+33% +$80.9K 0.03% 224
2025
Q1 		$283K Buy
+2,279
New +$297K 0.04% 202

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Caliber Wealth Management (Kansas)'s JAZZ Position: Q2 2026 in Review

Caliber Wealth Management (Kansas) reduced its Jazz Pharmaceuticals (JAZZ) stake by 33% in Q2 2026, selling an estimated $90.9K and leaving 850 shares worth $205K. The position accounts for 0.02% of the portfolio, ranked #294.

Caliber Wealth Management (Kansas) first reported a position in JAZZ in Q1 2025 and has held it in 6 quarters since. The position peaked at $321K in Q2 2025. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Caliber Wealth Management (Kansas) held 850 shares of Jazz Pharmaceuticals worth $205K as of Q2 2026.
  • Caliber Wealth Management (Kansas) sold 415 Jazz Pharmaceuticals shares in Q2 2026, an estimated $90.9K.
  • Jazz Pharmaceuticals made up 0.02% of Caliber Wealth Management (Kansas)'s portfolio in Q2 2026, its #294 holding.
  • Caliber Wealth Management (Kansas) first reported a position in Jazz Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • Caliber Wealth Management (Kansas)'s Jazz Pharmaceuticals position peaked at $321K in Q2 2025.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Caliber Wealth Management (Kansas)'s 13F filing for Q2 2026, filed 22 Jul 2026.